ARCH Venture Partners
Overview
ARCH Venture Partners is a venture capital firm that invests in early-stage biotechnology companies, with a focus on companies formed around breakthrough technologies. They also invest in companies in the life sciences, physical sciences and information technology sectors. The firm co-founds companies with leading scientists and entrepreneurs, commercializing technologies developed at academic institutions, corporate research groups and national laboratories.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Prometheus | Jun 2026 | Series B | - |
| Salma Health | Feb 2026 | Series A | Lead |
| Mirador Therapeutics | Jan 2026 | Series B | Co-investor |
| Parabilis Medicines | Jan 2026 | Series F | Co-investor |
| Vizgen | Jan 2026 | Series E | Lead |
Key People
Clint Bybee
Co-Founder and Managing Director Emeritus
Keith Crandell
Co-Founder and Managing Director
Robert Nelsen
Co-Founder and Managing Director
Erik Mogalian
Chief Executive Officer
Brian Wang
General Partner
Steve Lazarus
Managing General Partner
Jay Markowitz
Senior Partner
Kristina Burow
Managing Director
Steve Gillis
Managing Director
Inca Coman
Venture Partner
Jake Bauer
Venture Partner
John Maraganore
Venture Partner
joseph jeong
Venture Partner
Kaye Foster
Venture Partner
Keith Lenden
Venture Partner
Kent Rogers
Venture Partner Advisor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
